Skip to Content
Translational Research Program (TRP)
Contact CIP
Show menu
Search this site
Last Updated: 03/22/23

Kidney SPOREs

According to the NCI's Surveillance, Epidemiology, and End Results Program (SEER) data, there will be an estimated 79,000 new cases of kidney and renal pelvis cancers and about 13,920 deaths in 2022. The average annual incidence rate in 2016-2020 was 17.3, and the average annual death rate in 2016-2020 was 3.5 per 100,000. Kidney cancer can affect both adults and children. Metastatic kidney cancer remains largely incurable in adults. Kidney cancer in children, known as Wilms tumor, is curable in most patients, but treatment often leaves life-long sequelae. SPORE programs in kidney cancer span a wide array of projects. The SPOREs in kidney cancer foster collaborations among experts in renal cancer generating new resources and research opportunities for scientific community.